REVIEWS  PET AND GYNECOLOGICAL TUMORS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 June;60(2):139-53

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

New radiotracers in gynecological cancer: beyond 18F-FDG

Amarnath CHALLAPALLI ✉

Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK

Imaging plays an important role in the management of gynecological cancers. There is a clinical need for noninvasive prognostic biomarkers to provide more detailed tumor characterization at the baseline and/or early during therapy, which may potentially improve outcomes and enable a personalized treatment approach. Imaging parameters derived from PET/CT techniques are emerging as promising imaging biomarkers. This review details the current evidence and future potential of functional imaging using non-2-deoxy-2-[18F]fluoro-D-glucose (FDG) tracers in gynecological cancers.